ScoreWhy is Northeast Pharmaceutical Group Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -0.84% and Operating profit at 4.58% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 5.42% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -0.84% and Operating profit at 4.58% over the last 5 years
3
The company has declared negative results for the last 5 consecutive quarters
- ROCE(HY) Lowest at 4.59%
- INTEREST COVERAGE RATIO(Q) Lowest at 315.6
- RAW MATERIAL COST(Y) Grown by 13.38% (YoY)
4
Below par performance in long term as well as near term
- Along with generating -14.89% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Northeast Pharmaceutical Group Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Northeast Pharmaceutical Group Co., Ltd.
-12.48%
0.23
25.34%
China Shanghai Composite
23.91%
1.73
13.79%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.84%
EBIT Growth (5y)
4.58%
EBIT to Interest (avg)
3.57
Debt to EBITDA (avg)
2.66
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
0.72
Tax Ratio
26.62%
Dividend Payout Ratio
30.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.23%
ROE (avg)
5.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
Price to Book Value
1.11
EV to EBIT
26.90
EV to EBITDA
9.97
EV to Capital Employed
1.11
EV to Sales
0.90
PEG Ratio
NA
Dividend Yield
2.28%
ROCE (Latest)
4.11%
ROE (Latest)
3.61%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,154.56 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 4.43 %
NET SALES(Q)
Highest at CNY 2,006.2 MM
-25What is not working for the Company
ROCE(HY)
Lowest at 4.59%
INTEREST COVERAGE RATIO(Q)
Lowest at 315.6
RAW MATERIAL COST(Y)
Grown by 13.38% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.33 times
OPERATING PROFIT(Q)
Lowest at CNY 33.61 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 1.68 %
PRE-TAX PROFIT(Q)
Lowest at CNY 31.13 MM
NET PROFIT(Q)
Lowest at CNY 28.38 MM
EPS(Q)
Lowest at CNY 0.02
Here's what is working for Northeast Pharmaceutical Group Co., Ltd.
Operating Cash Flow
Highest at CNY 1,154.56 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Net Sales
Highest at CNY 2,006.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Debt-Equity Ratio
Lowest at 4.43 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Northeast Pharmaceutical Group Co., Ltd.
Pre-Tax Profit
At CNY 31.13 MM has Fallen at -59.34%
over average net sales of the previous four periods of CNY 76.58 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 28.38 MM has Fallen at -56.32%
over average net sales of the previous four periods of CNY 64.97 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest Coverage Ratio
Lowest at 315.6
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Operating Profit
Lowest at CNY 33.61 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 1.68 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 31.13 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY 28.38 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY 0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Debtors Turnover Ratio
Lowest at 2.33 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 13.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
